1 / 4

Pericardial Disease Market Trends, Size, Competitive Analysis and Forecast 2021-

The global pericardial disease market is anticipated to grow at a CAGR of around 5.5% during the forecast period. Pericardial disease is a medical condition that involves swelling and irritation in the pericardium.

Meenoo
Download Presentation

Pericardial Disease Market Trends, Size, Competitive Analysis and Forecast 2021-

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research Pericardial Disease Market, Size, Share, Analysis Report & Forecast to 2027 To Market: https://www.omrglobal.com/request-sample/pericardial-disease-market Request a Sample of our Report on Pericardial Disease Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

  2. The global pericardial disease market global pericardial disease market is anticipated to grow at a CAGR of around 5.5% during the forecast period (2021-2027). The factors attributing to the growth of the market include the growing geriatric population and rising prevalence of the pericardial disease across the globe. According to United Nations, Department of Economic and Social Affairs report for World Population Ageing 2019, by 2050, 1 in 6 people in the world will be over the age of 65, up from 1 in 11 in 2019. In line with this, there were 703 million persons aged 65 years or over in the world in 2019. The number of older persons is projected to double to 1.5 billion in 2050. Globally, the share of the population aged 65 years or over increased from 6.0% in 1990 to 9.0% in 2019. That proportion is projected to rise further to 16.0% by 2050, so that one in six people in the world will be aged 65 years or over. Though, geriatric populations are more vulnerable to pericardial disease creates demands for advanced treatments, thus higher growth in the market can be seen in upcoming years. Moreover, the rising cardiac diseases are expected to increase the sales for the drugs and treatments associated with the diseases. (Get 15% Discount on Buying this Report) A full Report of Pericardial Disease Market is Available at: https://www.omrglobal.com/industry- reports/pericardial-disease-market By geography, Eastern and South-Eastern Asia and Latin America and the Caribbean are the regions with a higher % of the aged population. In Eastern and South-Eastern Asia, the aged population has increased from 6% in 1990 to 11% in 2019, and from 5% to 9% in Latin America and the Caribbean in respective years. Moreover, the developments in the treatments and FDA approvals to the drugs launched by the market players can be expected to further increase the global pericardial diseases market growth. Market Coverage •The market number available for – 2020-2027 •Base year- 2020 •Forecast period- 2021-2027 Segment Covered- •By Application •By Function Regions Covered- •North America •Europe •Asia-Pacific •Rest of the World •Competitive Landscape- Teva Pharmaceutical Industries Ltd., AstraZeneca PLC, Abbott Laboratories, Edwards Lifesciences Corp, Integra LifeSciences Corp, among others. To Market: https://www.omrglobal.com/request-sample/pericardial-disease-market Request a Sample of our Report on Pericardial Disease Global Pericardial Disease Market Report Segment By Type •Acute Pericarditis •Chronic Pericarditis

  3. •Recurrent Pericarditis By Diagnosis Method •Chest X-Ray •Cardiac MRI •Cardiac CT Scan •Echocardiography •Electrocardiography (EKG) •Others (Blood Test) By Treatment Approach •Nonsteroidal Anti-Inflammatory Agents (NSAIDS) Drugs •Pericardiectomy Regional Analysis North America •United States •Canada Europe •UK •Germany •Spain •France •Italy •Rest of Europe Asia-Pacific •India •China •Japan •Rest of APAC Rest of The World •Latin America •Middle East & Africa Company Profiles •Abbott Laboratories •AliveCor, Inc. •AstraZeneca PLC •Bayer AG •CardioComm Solutions, Inc. •Coloplast Corp. •CryoLife, Inc. •Edwards Lifesciences Corp. •General Electric Co.

  4. •Integra LifeSciences Corp. •Kiniksa Pharmaceuticals, Ltd. •LivaNova PLC •Merck & Co., Inc. •Teva Pharmaceutical Industries Ltd. •VectraCor, Inc. Reasons to Buying From us – 1. We cover more than 15 major industries, further segmented into more than 90 sectors. 2. More than 120 countries are for analysis. 3. Over 100+ paid data sources mined for investigation. 4. Our expert research analysts answer all your questions before and after purchasing your report. For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report- customization/pericardial-disease-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research- based services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 7803040404

More Related